A fluorescent sensor-based tripodal-Bodipy for Cu (II) ions: bio-imaging on cells

Abstract

A general synthetic method was improved to synthesize a chemosensor based on a tripodal Bodipy (t-BODIPY) structure. The product and its intermediate products were successfully prepared and fully characterized. The metal ion sensing performance of the tripodal compound was evaluated by UV/Vis and fluorescence spectroscopies. According to the obtained data, t-BODIPY is a selective and sensitive fluorescence probe for detection of Cu²⁺ ions in the presence and in the absence of competing ions. This chemosensor presents relatively a low detection limit of 5.4×10⁻⁷ M for Cu²⁺. Bio-imaging studies on living yeast cells suggest that t-BODIPY has some advantages over other chemosensors to recognize copper (II) ions.

1. Introduction

Sensitive and selective recognition of metal ions is a crucial problem in many branches of science and engineering. The use of fluorescence sensor systems is undoubtedly the most advantageous technique for metal determination when compared to other conventional analytical techniques [1–3]. Metal ions causing pollution can interact with the sensor ligands through complexation, which would lead to a change in its fluorescence wavelength or intensity [4–6]. The use of Bodipy compounds has been reported in the field of fluorescent probes for the detection of various cations [7–9]. Reportedly, Bodipy is of noteworthy synthetic versatility, high solubility, stability, and optical properties Bodipy can also be used as a ligand for metals, which require different coordination spheres [10–13]. Although these Bodipy fluorescent compounds exhibited a good selectivity&sensitivity for the recognition of metal cations, the reported chemosensors were not soluble in pure water [14–17]. The solubility in aqueous or half-aqueous media is very important to develop biological applications. The number of studies based on Bodipy containing molecules soluble in aqueous or half-aqueous media in the field of sensor science is relatively low [18–23].

With these points in mind, we decided to design a tripodal Bodipy derivative (t-BODIPY) including donor atoms (nitrogen and oxygen) of ligands in order to improve water solubility. It is estimated that the Bodipy structure, which contains multiple donor atoms, can selectively bind to metal cations. Due to their fluorescent sensor properties, t-BODIPY may find practical applications in the future.

2. Experimental methods

Chemicals were supplied by Sigma-Aldrich, Acros and Alfa Aesar. Deuterated solvents were purchased from Merck. Except for solvents, which were degassed with argon for 30 min, all reagents were used without further purification. Nuclear Magnetic Resonance (NMR) spectra (¹H, ¹¹B, ¹³C-NMR and ¹⁹F) were measured on a Varian (400 MHz) and Bruker (600 Mhz) spectrophotometers at 25 °C. FT-IR measurements were obtained from a Bruker spectrophotometer (Vertex 70/80). The elemental analysis was calculated using a TruSpec analyser. The microscopy (lens: 100×, 50×, 20×, 10×, 4×) images of yeast cells were performed using an Olympus microscope. The cell images were taken by using a CCD camera having million-pixel resolution (DP70 12.5). The images were captured with DP Manager software. FTIC filter was performed for the fluorescence light. The absorption and emission measurements were performed by acetate salts in half-aqueous medium using a Shimadzu 1280 apparatus and PerkinElmer LS 55, respectively. Fresh compressed yeast was purchased from a local grocery store and suspended in an Eppendorf tube with ultrapure water at a concentration of about 30 mg/mL. To purify from impurities, the same processes were repeated 3 times after centrifugation with ultrapure water. The surface of the yeast cells was charged PAH (Poly(allylamine hydrochloride)) (0.5 M NaCl in 10 mg/mL solution) with polyelectrolyte. This process was mixed with 2 mL of PAH/aqueous solution of 300 μL aqueous yeast cell suspension, incubated for 10 min, and the suspension was centrifuged. The supernatant polyelectrolyte was removed, and the yeast cells were washed four times with ultrapure water. Similarly, yeast cells were mixed with t-BODIPY, which was incubated for 15 min. Then, the suspension was centrifuged. The supernatant free t-BODIPY was detached, and the yeast cells were washed three times with distilled water. The prepared yeast cells were suspended and examined by optical and fluorescence microscopy.

2.1. Synthesis

2.1.1. The preparing of.8-{4-(chloromethyl)phenyl.}-2,6-diethyl-4,4-difluoro-1,3,5,7-tetramethyl-4-bora-3a,4a-diaza-s-indacene (Compound 1)

Compound 1 was synthesized by a known method in our reported previous articles [24]. 4-(chloromethyl)benzoylchloride (0.01. mol, 1.875 g) was injected using a syringe to the solution of Kryptopyrrole (2.6 mL, 0.02 mol ) in DCM, 200 mL at r. t.. under argon. Then, the final mixture was reacted for 20 min. Following the solution being cooled, triethylamine (2.5 mL) was added to the solution. It was mixed at r.t. for 30 min, and BF₃.EtO₂ (2 mL) was finally injected by a syringe. The solution was refluxed in 70 °C for 20 min, and the raw product was purified by a mixture of EtOAc/cyclohexane in 1:8 ratio (yield 39%, 3.45 g). M. P. 188–190 °C. ¹H NMR [CDCl₃, 400 MHz]: 7.43 (Ar, d, J=7.8, Hz, 2H), 7.21 (ArH, d, J=7.8, 2H), 4.64 (2H, CH₂, s), 2.45 (6H, CH₃, s) 2.24 (4H, CH₂, q) 1.28 (6H, CH₃, s) 0.91 (CH₃, t, J=8.0, 6H). ¹³C NMR [CDCl₃,100 MHz]: δ (ppm); 153.99, 139.53, 138.87, 135.76, 135.99, 132.98, 130.65, 129.01, 128.54, 45.65, 16.91, 14.65, 12.55, 11.65. Analy. Cal. for (%) C₂₄ N₂H₂₈F₂ClB: C, 67.22; N, 6.53 H, 6.58; Found: C, 66.99; N, 6.12, H, 6.98. MS for C₂₄N₂ H₂₈F₂ClB: 428 [M+H]⁺.

2.1.2. The preparing of (8-{4-(azidomethyl)phenyl}.-2,6-diethyl-4,4-difluoro-1,3,5,7-tetra. methyl-4-bora-3a,4a-diaza-s-indacene) (Compound 2)

NaN₃ (0.688 g, 1.06 mol) and Compound 1 (0.88 mmol) were stirred in DMF (40 mL) for overnight at r. t. under N₂ [24]. The mixture was extracted with water/ diethyl ether. The diethyl ether phases were collected and dried with Na₂SO₄. Diethyl ether was evaporated, and raw product was obtained using column chromatography (EtOAc/Petroleum ether 1:3) (1.10 g, 94%). M. P.: 139–141 °C. ¹H-NMR [CDCl₃, 400 MHz]: 7.46 (2H ArH, d), 7.32 (2H, ArH, d) 4.49 (2H, CH₂, s), 2.58 (6H, CH₃, s), 2.33 (4H, CH₂, q), 1.29 (6H, CH₃, s), 0.98 (6H, CH₃, t). ¹³C NMR [CDCl₃, 100 MHz]: δ (ppm); 11.98. 12.33, 15.03, 17.45, 55.35, 129.04, 128.28, 130.82, 132.94, 135.63, 135.99, 138.04, 138.98, 154.05. Elem. Analy Found: H, 6.68; C, 66.39; N, 16.14, Analytical Cal. for (%) C₂₄H₂₈BF₂N₅: H, 6.48; C, 66.22; N, 16.09.

2.1.3. The synthesis of (8-{4-(aminomethyl)phenyl}.-2,6-diethyl-4,4.-difluoro-1,3,5,7-tetramethyl.-4-bora-3a,4a-diaza.-s-indacene) (Compound 3)

Compound 2 (0.01 mol, 0.9 g) and TPP (triphenylphosphine) (0.262 2 g, 0.01 mol,) were dissolved in dry THF (150 mL). Following six hours, water (2 drops) was dropped [24]. The solution was mixed for 24 h. The purification of the product was accomplished with a column by a long process (DCM/MeOH 10:1). The yield is calculated as 71% (0.31 g). M.P.≈170 °C.

¹H-NMR [CDCl₃, 400 MHz]: 7.45 (2H, ArH, d,), 7.27 (2H, ArH, d), 4.04 (2H, CH₂, s), 2.57 (6H, CH₃, s) 2.38 (4H, CH₂, q) 1.23 (6H, CH₃, s) 1.03 (6H, CH₃, t). ¹³C NMR [CDCl₃, 100 MHz]: δ (ppm); 11.96, 12.55, 14.92, 17.52, 46.32, 127.88, 128.21, 130.98, 133.12, 135.02, 137.02, 140.02, 142.13, 154.36. Analytical Found: H, 7.69; C, 70.56; N, 10.11. Cal. for (%) C₂₄H₃₀BF₂N₃: H, 7.38; C, 70.43; N, 10.28.

2.1.4. The synthesis of t-BODIPY

To a mixture of Compound 3 (1 mmol, 0.41 g,) in dichloromethane, 0.5 mL of diethylisopyropylamine was injected at −4°C (salt./ice). 0.15 g of 1,3,5-benzentricarbonyl chloride was poured to this mixture at r. t. and stirred for 72 h. The solution was extracted in chloroform/water for three times, and the crude residue was drawn into the chloroform. The product was purified using column chromatography (Petroleum Ether/EtOAc; 1:1 after the chloroform was evaporated in vacuo. Dark red solid was obtained. 0.16 g, Yield: 28% (Scheme). ¹H-NMR [CDCl₃, 400 MHz]: 8.65 (3H, bs, NH), 8.39 (3H, s, ArH), 7.48–7.15 (12H, m, ArH), 4.48 (CH₂, s, 6H,), 2.48 (CH₃, s, 18H,), 2.15 (CH₂, q, 12H), 1.60 (CH₃, s, 18H), 1.12 (CH₃, t, 12H). ¹³C-NMR [CDCl₃, 100 MHz]: 167.8, 148.3, 145.4, 140.2, 138.5, 137.2, 135.1, 130.1, 129.7, 125.3, 123.7, 118.3, 114.2, 43.1, 18.2, 17.2, 15.1, 14.1, 12.2, 11.3. Analy. Calcl. (%) C₈₁H₉₀B₃F₆N₉O₃; C, 70.29; H,. 6.55; N, 9.11 Found; C, 70.52; H, 6.77; N, 9.01. MS [+H⁺]; m/z: 1385.1

Scheme.

The obtaining route of t-BODIPY.

3. Results and discussion

In the absorption study for the chemosensor, the solution of the ligand was prepared at concentrations of 1.10⁻⁶ M in methanol, and counter ions (Mn (II), Cr (III), Fe (II), Li (I), Co (II), Zn (II), Al (III), Ni (II), Ga (III), Cd (II), Cu (II), Ag (I), Hg (II)) solutions were prepared in water at 20.10⁻⁶ M concentration. The absorption, emission, and the related spectroscopic calculations were made by mixings of metal salts and t-BODIPY solutions in a 1:1 ratio (v:v).

When FT-IR spectra of compounds (Figures S1–S4) was examined, peaks around 2800–3000 cm⁻¹ were assigned to aromatic or aliphatic C-H vibrations and the peaks around 1680 cm⁻¹ are attributed to C=O vibrations. Moreover, C=C and C=N vibration peaks were observed among 1600–1400 cm⁻¹ as multisignals and 1640 cm⁻¹, respectively.

Four main transitions were observed in the absorption spectrum of t-BODIPY where these bands appeared around 230, 270, 370, and 530 nm, respectively. The molar absorption coefficient was calculated as 161000 M⁻¹.cm⁻¹ due to behaviors of different auxochrome moieties involving the lone pair of electrons while the absorption maximum is not shifted.

The band around 370 nm indicates that the π-π * transitions assigned to the aromatic groups of the chemosensor t-BODIPY in a three-way molecular structure (Figure 1a). Also, another sharp band observed at 530 nm indicates the classical S₀-S transition of Bodipy compounds. In contrast to minor changes after the interaction between most metal ions with t-BODIPY solutions, Cu (II) ions lead to a significant change in the absorption band around 280 nm. This rising band may be associated with the formation of a complex. Since t-BODIPY's absorption spectrum showed a significant change only in the presence of Cu (II) ions, t-BODIPY might be used to detect Cu (II) ions. It is thought that the Cu (II) ion interacts with the nitrogen and oxygen atoms of the amide parts of t-BODIPY to form a complex (Figure 1b and S18). The aromatic region peaks slightly shifted to a different ppm value while NH broad peak completely disappeared and compared (Figure S19,S20). NMR spectrum of the complex form between t-BODIPY and Cu (II) was also supported with both Job plot and previous literature [25].

Figure 1.

Absorption spectral changes of t-BODIPY upon addition of various metal ions ((Cr (III), Li (I), Fe (II), Mn (II), Ni (II), Co (II), Zn (II), Cu (II), Al (III), Cd (II), Ga (III), Ag (I), Hg (II)).

To support absorption results, the emission spectra of the t-BODIPY-metal ion mixtures were also investigated (Figure 2). The fluorescence spectra of the prepared t-BODIPY and t-BODIPY-metal ion mixtures were excited at 470 nm to an optimum result. As shown in

Figure 2.

Fluorescence spectral changes of t-BODIPY upon addition of various metal ions (Cr (III), Li (I), Fe (II), Mn (II), Ni (II), Co(II), Zn (II), Cu (II), Al (III), Cd (II), Ga (III), Ag (I), Hg (II)); λex:470 nm.

Figure 2, t-BODIPY emission band at 545 nm has changed only in the presence of copper (II) ion just like in the absorption studies. Here, the fluorescence intensity of t-BODIPY has changed significantly, quenched (over 90%) towards 60 units from a fluorescence intensity of 700 units. This effect can likewise be attributed to the complex interaction between nitrogen and oxygen atoms in the amide groups and copper (II) ions. Moreover, the emission intensity of t-BODIPY did not almost change in the presence of other copper salts (F⁻, Cl⁻, I⁻, Br⁻, HCO₃⁻, CO₃²⁻, HSO₃⁻, SO₄²⁻, NO₃⁻) (Figure S21).

Another selectivity study of t-BODIPY, where copper (II) ion sensitivity was also confirmed, was conducted. For this aim, t-BODIPY+ Cu (II) + other ion solutions were prepared. Other studied metal ions did not change the selectivity of the copper (II), and the intensity of the quenched fluorescence of t-BODIPY did not change (Figure 3).

Figure 3.

Fluorescence intensities around 548 nm of t-BODIPY&Cu (II) ion mixture in the presence of a series of metal ions (Cr(III), Li (I), Fe (II), Mn (II), Ni (II), Co (II), Zn (II), Cu (II), Al(III), Cd (II), Ga (III), Ag (I), Hg (II)).

Emission measurements were taken at 1, 2, 3, 4, 5, 10, 15, and 20 min after adding of metal ion for the best response time for t-BODIPY, which has a sensor feature for copper ions (Figure 4). As it can be understood from Figure 4, t-BODIPY's fluorescence intensity decreased continuously, and, after 10 min, this effect almost ended. The ideal response time of this t-BODIPY was determined as ten minutes at room temperature.

Figure 4.

Response time experiments based-on the complexation between Cu (II) and t-BODIPY in the half-aqueous medium(λem_max = 547 nm).

The stoichiometry of the complexometric interaction between Cu (II) ion and t-BODIPY was determined using Job’s method (Figure 5). As can be seen from Figure 5, the minimum emission is located at the center, at the point corresponding to the 0.5 mole fraction with 1/1 metal/ligand ratio. Due to the N atom in the amide group being a hydrogen bond donor, it plays a vital position in the complex reaction.

Figure 5.

Job’s plot graph of the complex carried out for t-BODIPY with Cu (II).

Stern-Volmer equation was used for the calculation of the binding constant in the complex. For this aim, the emission maxima of Cu (II)/t-BODIPY solutions were obtained (Figure 6).

Figure 6.

The emission intensities ratio (F₀/F) around 547 nm plotted against copper (II) ion concentrations (1.10⁻⁶–2.5×10⁻⁵ M)(λem_max = 548 nm).

$${\mathbf{F}}_0/\mathbf{F}=1+{\mathbf{K}}_{\mathbf{sv}}\hspace{0.17em}[\mathbf{C}]$$

Where K; is the binding constant, F₀; Emission of t-BODIPY in the absence of copper (II), F; fluorescence intensity in the presence of Cu (II) ion, C; the concentration of Cu (II) ion. As can be seen from Figure 6, the F₀/F ratio at different concentrations seemed linear and increasing curve. The binding constant (Ksv) was calculated from this equation as 1.68×10⁵ M⁻¹.

The limit of detection (LOD) was performed from some parameters (the stand. dev. blank) that affected the accuracy of the model performed to determine concentrations from the fluorescence intensities.

$$\text{LOD}=3\text{s}/\text{F}$$

In there, s is the stand. dev. of the blank mixture, F is the false of the LOD curve. The limit of detection (LOD) of copper ion was calculated as 5.4×10⁻⁷ M by using the fluorescence intensities of t-BODIPY in Figure 6. When the result is compared with our previous paper concluding yeast cell studies, it can be evaluated as a worse value [29]. However, this LOD value can be accepted based on the U.S.’s defined contaminant level in tap water, which is 20 μM, for copper ions; hence, the probe, t-BODIPY, is effective for the recognition of copper (II) in real samples. t-BODIPY has a lower LOD that is beneficial for the recognition of copper (II) in the half-aqueous medium when compared with previous literature, [15,21,26,27]. The selectivity performance of t-BODIPY towards copper (II) was also compared with some published probes for copper (II) through a complex mechanism. As understood from Table, t-BODIPY can challenge the detection of copper ions toward some Bodipy-based fluorescent chemosensors operated with turn-off&PET mechanism [15,21,26,27]. The emission intense of t-BODIPY is quenched by the amide fragments on triple Bodipy units. t-BODIPY has many attractive compensations in terms of detection limit, sensing techniques, and yeast living-cells.

Table.

The comparison of Bodipy chemosensors for Cu (II) with our study.

Mechanism Type	Limit of detection (M)	Ref.
Turn-off & PET	0.11× 10−6	[26]
Turn-off & PET	3.97 × 10−6	[15]
Turn-off & PET	5.36 × 10−6	[15]
Turn-off & PET	0.124 × 10−6	[21]
Turn-off & PET-aggregation	-	[28]
Turn-off & PET	3.6 10−7	[29]
Turn-off & PET	5.4×10−7	Our study

The stability of t-BODIPY-Cu (II) was also determined with Cu (II) and EDTA solutions. The solution of Cu (II) (20.10⁻⁶ M) was firstly added to the mixture of t-BODIPY (1.10⁻⁶ M) and ligand’s fluorescence intensity quenched. Then, EDTA (20.10⁻⁶ M) was dropped to this mixture, and fluorescence intensity reincreased quickly toward 800 units (Figure 7). As shown in Figure 7, the fluorescence intensity of t-BODIPY quenched in the presence of copper (II) continued to be stable after four times. The recovery rate of the fluorescence intensity following the first adding of EDTA was above 85%, and the three serial recovery rates were slightly reduced.

Figure 7.

The sequential recognition of t-BODIPY (1.10⁻⁶ M) upon alternate addition of Cu(II) and EDTA (20.10⁻⁶ M) inmethanol/H₂O (9:1 v/v) system (λ_ex:470).

The yeast cells photographed with bright-field optical microscopy (Figures 8a, 8b, 8c). The yeast cells were interacted with t-BODIPY and investigated under a fluorescence microscope after the polyelectrolyte coating. As it can be observed from Figure 8b, t-BODIPY interacted with the yeast cells, and then Figure 8c supported that copper (II) ion quenched the emission intensity of t-BODIPY.

Figure 8.

Optical microscope photo of yeast cells (a) and fluorescence microscope image (b) of yeast cells after coupling with t-BODIPY fluorescence microscopy image after adding Cu (II) solution to Bodily yeast cells (c).

4. Conclusion

In summary, a known tripodal fluorescence chemosensor (t-BODIPY) was prepared by the proposed synthetic strategy and showed sensitivity and selectivity for copper (II) ion. The emission and absorption values of t-BODIPY only changed in the presence of copper(II) ion, and other ions did not cause any change. In the presence of copper (II) ion, the emission of t-BODIPY showed a significant damping effect without causing any wavelength shift, and the fluorescence intensity decreased. This situation has revealed an effective energy mechanism, and the high sensitivity of t-BODIPY to Cu (II) ions has been demonstrated. The competing ion study was performed for t-BODIPY, which has been proven to be sensitive to copper ions and did not cause any significant changes to the t-BODIPY/Cu (II) complex. t-BODIPY can be used as a selective&sensitive probe for the copper (II) ion; LOD was determined as 5.4×10⁻⁷ M. t-BODIPY was effectively applied in the bio-imaging of copper (II) in yeast cells.

Experimental Section

Materials, instruments, and methods

Chemicals were supplied by Sigma-Aldrich, Acros and Alfa Aesar. Deuterated solvents were purchased from Merck. Except for solvents, which were degassed with argon for 30 min, all reagents were used without further purification. Nuclear Magnetic Resonance (NMR) spectra (¹H, ¹¹B, ¹⁹F, and ¹³C-NMR) were measured on a Varian 400 MHz and Bruker 600 Mhz spectrophotometers at 25 °C. FT-IR measurements were measured using a Bruker (Vertex 70) spectrophotometer, and elemental analysis was performed using a TruSpec analyser. The microscopy (lens: 100×, 50×, 20×, 10×, 4×) images of yeast cells were performed using an Olympus microscope. The images were taken by using a CCD camera (DP70 12.5 million-pixel resolution). The images were captured with DP Manager software. FTIC filter was used for the fluorescence light. The absorption and emission data were performed by metal acetate in a half aqueous medium using a Shimadzu 1280 apparatus and PerkinElmer LS 55, respectively. Fresh compressed yeast was purchased from a local grocery store and suspended in an Eppendorf tube with ultrapure water at a concentration of about 30 mg/mL. To purify from impurities, the same processes were repeated 3 times after centrifugation with ultrapure water. The surface of the yeast cells was charged PAH (Poly(allylamine hydrochloride)) (0.5 M NaCl in 10 mg/mL solution) with polyelectrolyte. This process was mixed with 2 mL of PAH/aqueous solution of 300 μL aqueous yeast cell suspension, incubated for 10 min and then centrifuged. The supernatant polyelectrolyte was removed, and the yeast cells were washed four times with ultrapure water. Similarly, yeast cells were mixed with t-BODIPY and incubated for 15 min and then centrifuged. The supernatant free t-BODIPY was removed, and the cells were washed three times with distilled water. The prepared yeast cells were suspended and examined by optical and fluorescence microscopy.

The synthesis of compounds

The synthesis of Compound 1 (8-{4-(chloromethyl)phenyl}-2,6-diethyl-4,4-difluoro-1,3,5,7-tetramethyl-4-bora-3a,4a-diaza-s-indacene)

Compound 1 was synthesized by a known method in our reported previous articles [24]. p-(chloromethyl)benzoyl chloride (1.875 g, 0.01 mol) was injected by a syringe to the solution of Kryptopyrrole (2.6 mL, 0.02 mol ) in DCM, 200 mL under argon atmosphere at r. t. Then, the mixture was stirred for 20 min. Following the solution was cooled, 2.5 mL of triethylamine was added to the solution, it was mixed at r.t. for 30 min, and boron trifluoride diethyl etherate (2 mL) was finally added by syringe. The mixture was refluxed at 70 °C for 20 min, and the residue was purified by a solution of cyclohexane/ethylacetate in 8:1 ratio (3.47 g, yield 40%). M. P. 189 °C. ¹H NMR [400 MHz, CDCl₃]: 7.43 (PhH, d, J=7.8, Hz, 2H), 7.21 (PhH, d, J=7.8, 2H), 4.64 (CH₂, s, 2H), 2.45 (CH₃, s, 6H) 2.24 (CH₂, q, 4H) 1.28 (CH₃, s, 6H) 0.91 (CH₃, t, J=8.0, 6H). ¹³C NMR [100 MHz, CDCl₃]: δ (ppm); 154.03, 139.49, 138.66, 135.88, 136.11, 133.02, 130.77, 128.98, 128.39, 45.65, 16.91, 14.65, 12.55, 11.65. Analytical Cal. for (%) C₂₄H₂₈N₂F₂ClB: H, 6.58; C, 67.22; N, 6.53; Found: H, 6.98; C, 66.99; N, 6.12. MS for C₂₄H₂₈N₂F₂ClB: 428 [M+H]⁺.

The synthesis of Compound 2 (8-{4-(azidomethyl)phenyl}-2,6-diethyl-4,4-difluoro-1,3,5,7-tetra methyl-4-bora-3a,4a-diaza-s-indacene)

NaN₃ (0.688 g, 1.06 mol) and Compound 1 (0.88 mmol) were stirred in N,N-dimethylformamide (40 mL) for overnight at room temperature under argon atmosphere [24]. The mixture was extracted with diethyl ether/water. The diethyl ether phases were collected, dried with Na₂SO₄. Diethyl ether was evaporated, and raw product was purified in column (ethylacetate/cyclohexane 1:3) (1.10 g, 95%). M. P.: 140 °C. ¹H-NMR [400 MHz, CDCl₃]: 7.46 (PhH, d, 2H), 7.32 (PhH, d, 2H,) 4.49 (CH₂, s, 2H,), 2.58 (CH₃, s, 6H), 2.33 (CH₂, q, 4H), 1.29 (CH₃, s, 6H,), 0.98 (CH₃, t, 6H). ¹³C NMR [100 MHz, CDCl₃]: δ (ppm); 154.05, 138.98, 138.04, 135.99, 135.63, 132.94, 130.82, 128.28, 129.04, 55.35, 17.45, 15.03, 12.33, 11.98. Analytical Cal. for (%) C₂₄H₂₈BF₂N₅: H, 6.48; C, 66.22; N, 16.09; Found: H, 6.68; C, 66.39; N, 16.14.

The synthesis of Compound 3 (8-{4-(aminomethyl)phenyl}-2,6-diethyl-4,4-difluoro-1,3,5,7-tetramethyl-4-bora-3a,4a-diaza-s-indacene)

Triphenylphosphine (0.01 mol, 0.262 2 g) and Compound 2 (0.01 mol, 0.9 g) were dissolved in dry THF (150 mL). Following six hours, 2 drops of distilled water were dropped [24]. The mixture was stirred for 24 h. The purification of the product was accomplished by a long/difficult procedure in column (dichloromethane/methanol 10:1). The yield is calculated as 71% (0.31 g). M.P.≈170 °C.

¹H-NMR [400 MHz, CDCl₃]: 7.45 (PhH, d, 2H), 7.27 (PhH, d, 2H) 4.04 (CH₂, s, 2H), 2.57 (CH₃, s, 6H) 2.38 (CH₂, q, 4H,) 1.23 (CH₃, s, 6H) 1.03 (CH₃, t, 6H). ¹³C NMR [100 MHz, CDCl₃]: δ (ppm); 154.36, 142.13, 140.02, 137.02, 135.02, 133.12, 130.98, 128.21, 127.88, 46.32, 17.52, 14.92, 12.55, 11.96. Analytical Cal. for (%) C₂₄H₃₀BF₂N₃: H, 7.38; C, 70.43; N, 10.28; Found: H, 7.68; C, 70.55; N, 10.11.

The synthesis of t-BODIPY

To a solution of Compound 3 (0.41 g, 1 mmol) in dichloromethane, 0.5 mL of diethylisopyropylamine was injected at −4 °C (salt-ice). Then, 0.15 g of 1,3,5-benzentricarbonyl chloride was poured to this solution at r. t. and stirred for 72 h. The mixture was extracted in water/chloroform for three times and the crude residue was drawn into the chloroform. The chloroform was evaporated in vacuo and the product was purified in the column (cyclohexane/ethylacetate; 1:1). Dark red solid was obtained. 0.16 g, Yield: 28% (Scheme 1). ¹H-NMR [400 MHz, CDCl₃]: 8.65 (bs, 3H, NH), 8.39 (s, 3H, ArH), 7.48–7.15 (m, 12H, ArH), 4.48 (s, 6H, CH₂), 2.48 (s, 18H, CH₃), 2.15 (q, 12H, CH₂), 1.60 (s, 18H, CH₃), 1.12 (t, 12H, CH₃). ¹³C-NMR [100 MHz CDCl₃]: 167.8, 148.3, 145.4, 140.2, 138.5, 137.2, 135.1, 130.1, 129.7, 125.3, 123.7, 118.3, 114.2, 43.1, 18.2, 17.2, 15.1, 14.1, 12.2, 11.3. Analy. Calcl. (%) C₈₁H₉₀B₃F₆N₉O₃; C, 70.29; H, 6.55; N, 9.11 Found; C, 70.52; H, 6.77; N, 9.01.

Figure S1

FT-IR spectrum of Compound 1.

Figure S2

FT-IR spectrum of Compound 2.

Figure S3

FT-IR spectrum of Compound 3.

Figure S4

FT-IR spectrum of t-BODIPY.

Figure S5

¹H-NMR spectrum of Compound 1.

Figure S6

¹H-NMR spectrum of Compound 2 (25 °C).

Figure S7

¹H-NMR spectrum of Compound 3 (25 °C).

Figure S8

¹H-NMR spectrum of t-BODIPY (25 °C).

Figure S9

¹³C-NMR spectrum of Compound 2 (25 °C).

Figure S10

¹³C-NMR spectrum of Compound 3 (25 °C).

Figure S11

¹³C-NMR spectrum of t-BODIPY (25 °C).

Figure S12

¹¹B-NMR spectrum of Compound 2 (25 °C).

Figure S13

¹¹B-NMR spectrum of Compound 3 (25 °C).

Figure S14

¹⁹F-NMR spectrum of Compound 2 (25 °C).

Figure S15

¹⁹F-NMR spectrum of Compound 3 (25 °C).

Figure S16

Mass spectrum of Compound 1.

Figure S17

Mass spectrum of Compound 3.

Figure S18

¹H NMR titration spectra of t-BODIPY upon addition of 1 equiv. Cu (II) in DMSO-d6 solution (25 °C).

Figure S19

Mass spectrum of t-BODIPY.

Figure S20

Comparation of ¹H NMR titration spectra of t-BODIPY and t-BODIPY-Cu (II) complex.

Figure S21

Fluorescence spectral changes of t-BODIPY upon addition of various anions (F⁻, Cl⁻, I⁻, Br⁻, CH₃COO⁻, HCO₃⁻, CO₃²⁻, HSO₃⁻, SO₄²⁻, NO₃⁻). λex:470 nm.

Funding Statement

The authors gratefully thank TUBITAK (Scientific and Technological Research Council of Turkey) (118Z039) for the financial support.